Brigham Young University, Provo, UT, USA.
J Athl Train. 2011 May-Jun;46(3):270-6. doi: 10.4085/1062-6050-46.3.270.
Iontophoresis is used frequently in physical medicine and rehabilitation, but many research techniques do not adequately measure it for depth of medicine delivery.
To determine if iontophoresis delivers lidocaine 5 mm under the surface of human skin.
Descriptive laboratory study.
Therapeutic modalities research laboratory.
Eight men and 5 women volunteers (age range = 21± 2.3 years) who had less than 5 mm of adipose tissue in the area we measured participated in the study.
INTERVENTION(S): We inserted a microdialysis probe 5 mm under the skin of both legs and into the triceps surae muscle groups of 10 participants. Microdialysis was performed for 60 minutes to allow a recovery period for local skin blood flow to return to baseline. We then delivered 2 mL of 1% lidocaine to the treatment leg via iontophoresis at 40 mA/min. Next, microdialysis was performed continuously in both legs during the treatment and for 30 minutes posttreatment to collect the lidocaine samples. After we had gathered the samples, several saline solutions with various amounts of lidocaine (0.005%, 0.025%, 0.05%, and 0.1 %) were prepared in vitro and analyzed. Although we did not intend to do so as a part of the original study, we also performed an identical follow-up study at 3 mm in 3 participants.
MAIN OUTCOME MEASURE(S): Both in vitro and in vivo samples were analyzed via reverse-phase high-performance liquid chromatography (RP-HPLC). A protocol for detection and quantification of lidocaine using RP-HPLC was followed.
We did not detect any measurable levels or concentrations of lidocaine in the 10 control samples. According to the RP-HPLC analysis, the 10 treatment samples also were negative for the presence of lidocaine. However, when we performed the study at 3 mm, microdialysis detected lidocaine in the 3 participants at this depth in the treatment leg only.
Measurable levels of lidocaine were not detected at 5 mm but were found at 3 mm. More studies are needed to determine the efficacy of microdialysis in measuring iontophoresis-delivered compounds.
电渗疗法在物理医学和康复领域经常使用,但许多研究技术无法充分测量其药物输送的深度。
确定电渗疗法是否能将利多卡因输送到人体皮肤下 5 毫米处。
描述性实验室研究。
治疗方式研究实验室。
8 名男性和 5 名女性志愿者(年龄范围=21±2.3 岁)参与了这项研究,他们在我们测量的区域的脂肪组织少于 5 毫米。
我们将微透析探针插入双腿皮肤下 5 毫米处,并插入 10 名参与者的比目鱼肌群。微透析进行了 60 分钟,以允许局部皮肤血流恢复到基线的恢复期。然后,我们以 40 mA/min 的电流通过电渗疗法将 2 mL 1%利多卡因输送到治疗腿。接下来,在治疗期间和治疗后 30 分钟内,在两条腿上连续进行微透析以收集利多卡因样本。收集完样本后,我们在体外制备了几种含有不同利多卡因浓度(0.005%、0.025%、0.05%和 0.1%)的盐水溶液并进行了分析。虽然我们最初并没有打算这样做,但我们在 3 名参与者中也进行了一项相同的 3 毫米后续研究。
通过反相高效液相色谱法(RP-HPLC)对体外和体内样本进行分析。采用 RP-HPLC 检测和定量利多卡因的方案。
我们在 10 个对照样本中均未检测到可测量的利多卡因水平或浓度。根据 RP-HPLC 分析,10 个治疗样本也未检测到利多卡因的存在。然而,当我们在 3 毫米处进行研究时,微透析仅在治疗腿的 3 名参与者的这个深度处检测到利多卡因。
在 5 毫米处未检测到可测量的利多卡因水平,但在 3 毫米处发现了。需要进一步研究来确定微透析在测量电渗疗法输送化合物方面的效果。